Literature DB >> 33497999

Intra-abdominal desmoplastic small round cell tumour in a 56-year-old female: Case report of a very rare presentation of an unusual tumour.

Jason Russell Laurens1, Adam John Frankel2, Bernard Mark Smithers3.   

Abstract

INTRODUCTION: This case report discusses the rare diagnosis of intra-abdominal desmoplastic small round cell tumour (DSRCT) in a 56-year-old female. PRESENTATION OF CASE: An incidental intra-abdominal lesion was found during investigation of joint pain. Ultrasound-guided biopsy suggested desmoid tumour, after undergoing laparotomy and en-bloc excision of the tumour due to concerning radiological progression, the final histology was desmoplastic small round cell tumour. At six-week follow-up imaging, no recurrence or metastatic disease was noted. She declined chemotherapy and specialist follow-up, electing to have routine follow up with her General Practitioner only. DISCUSSION: Intra-abdominal DSRCT is rare and mainly seen in young males. To our knowledge, this is the only reported case of DSRCT in a female over the age of 50.
CONCLUSION: There should be timely discussion between different surgical units to provide efficient care. Any disparity between radiological and histological appearance should prompt further review and investigation in order to ensure misdiagnosis is avoided and appropriate treatment is provided. Despite cytoreductive surgery, survival is dismal due to the aggressive nature of the tumour, and its low numbers limiting adequate study into post diagnosis care.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Case report; Desmoplastic small round cell tumour; Intra-abdominal tumour; Surgical oncology

Year:  2021        PMID: 33497999      PMCID: PMC7840787          DOI: 10.1016/j.ijscr.2021.01.058

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Presentation of case

A 56-year-old female had an incidental large intra-abdominal mass found on single-photon emission computed tomography (SPECT) performed for investigation of joint pain. Her medical history was osteoarthritis with chronic pain, asthma, obstructive sleep apnoea, gastro-oesophageal reflux disease, bipolar disorder and morbid obesity with a BMI of 53 kg/m2. Her chronic pain management in the community included paracetamol 1 g QID, multiple opiates (250 mg daily oral morphine equivalent), gabapentin 300 mg BD, diazepam 5 mg TDS and temazepam 5 mg nocte. Her surgical history included a total abdominal hysterectomy, laparoscopic cholecystectomy and umbilical hernia repair with preperitoneal mesh. There was no relevant family history. She was referred to the local regional general surgery department who arranged an abdominal computed tomography (CT) scan to define the mass. Six weeks after the SPECT, she underwent ultrasound-guided core biopsy. Histology reported desmoid fibromatosis. She was referred to our tertiary hospital-based sarcoma service for an opinion and management. Our multi-disciplinary team (MDT) felt that the radiological appearances were unusual for desmoid fibromatosis and a repeat CT at one month was recommended to assess progress Fig. 1. In parallel and unknown to us, the local team had requested a CT/PET which ws performed 10 days after the MDT meeting (3 months post initial CT). This demonstrated FDG avidity of the tumour with some free peritoneal fluid. The repeat CT we arranged occurred three weeks later and suggested tumour necrosis with possible rupture, associated with large volume ascites Fig. 2. Two days after this, she attended our clinic as scheduled. Given the progressive change on imaging did not support a diagnosis of desmoid tumour, and she lived 150 km away, she was admitted. At this time, she had nausea, without vomiting, normal observations and a distended and centrally tender abdomen. A full blood count, renal and hepatic function tests and C-reactive protein were all unremarkable. She was counselled to undergo an exploratory laparotomy and likely resection based on intra-operative findings.
Fig. 1

CT abdomen, showing intact intra-abdominal tumour.

Fig. 2

CT abdomen, showing suggested tumour rupture and free fluid.

CT abdomen, showing intact intra-abdominal tumour. CT abdomen, showing suggested tumour rupture and free fluid. Under general anaesthetic, Professor Smithers performed a midline laparotomy, which revealed 4.5 L of straw-coloured ascites and a grapefruit-sized irregular pale mass in the mid-small bowel mesentery. A loop of small bowel, a short segment of transverse colon and three sections of omentum were densely adherent to the mass. The adjacent omentum contained multiple large veins approaching 1 cm in diameter but there was no evidence of varices elsewhere. The mass was excised en-bloc with bowel anastomoses Fig. 3. A nearby portion of omentum containing an enlarged firm vein was resected separately. She was admitted to the high dependency unit, to monitor her respiratory function with concerns regarding her pre-operative opiate and benzodiazepine use. She recovered quickly and was discharged home on post-operative day six with normal gut function and near-baseline mobility.
Fig. 3

Photo of en-block excision of tumour.

Photo of en-block excision of tumour. The final histology was reported as a 150 mm desmoplastic small round cell tumour (DSRCT) with adjacent small tumour deposits and foci of vascular invasion. The separate specimen of omentun showed a large vein occluded by tumour thrombus. Immunohistochemistry demonstrated positive nuclear staining for WT1 and SATB2. Fluorescence In-Situ Hybridisation (FISH) demonstrated rearrangement of the EWS-R1 gene region. Cytokeratin staining was negative, with a final diagnosis of DSRCT (Fig. 4, Fig. 5).
Fig. 4

H&E histology slide.

Fig. 5

H&E histology slide.

H&E histology slide. H&E histology slide. The operative findings and pathology were discussed at our MDT and it was recommended to repeat the CT/PET at 6 weeks. This showed no evidence of recurrence or metastatic disease. Following consultations with a medical oncologist, she chose not to undergo systemic therapy and declined clinical follow-up and repeat imaging. She did accept ongoing follow-up only with her general practitioner.

Discussion

Intra-abdominal desmoplastic small round cell tumour (IADSRCT) is a rare and often aggressive tumour with generally poor prognosis [1,11]. First described by Gerald and Rosai in 1989 [2], it has slowly built a presence in the literature although there are still few recorded cases. The usual presentation of IADSRCT is with abdominal pain [[3], [4], [5]]. It is rarely seen in females (4:1 M:F) and is usually diagnosed before the age of 30 [5]. To our knowledge, this is the only report of a case in a female over the age of 50. Radiological studies are not specific, and diagnosis rests on histology with cytogenetic studies confirming the presence of the unique chromosomal translocation t(11:22) (p13;q12). This genomic change results in the functional fusion of the EWS and WT1 genes [6,7], similar to Ewing sarcoma. The rarity of the pathology means there are currently no evidence-based therapeutic guidelines on post-resection management, although several small series have shown partial response to adjuvant chemotherapy (P6 Protocol) [4,5,8]. In select cases, cytoreductive surgery (CRS) and intraperitoneal hyperthermic chemoperfusion (HIPEC) has been provided; one case had recurrence at 8.85 months [11] while a small phase 2 trial showed overall survival of 44.3 months [10]. It should be noted the patients who underwent CRS + HIPEC were young, otherwise healthy males, while our patient is a late middle-age female and morbidly obese with numerous comorbidities. It seems that regardless of treatment strategy, the long-term prognosis is very poor.

Conclusion

While this case report describes an unusual presentation of a rare tumour, the broader lessons are that there should be clear and timely communication between different surgical units to provide efficient care, and that disparity between radiological and histological appearance should prompt further review and investigation. This will help to ensure that misdiagnosis is avoided, appropriate treatment is provided in a timely fashion, aiming to minimise adverse outcomes. This case has been reported in line with the SCARE 2018 criteria [9].

Declaration of Competing Interest

The authors report no declarations of interest.

Funding

No sources of funding required for this case report.

Ethical approval

No ethics approval was sought as this is a retrospective de-identified case report.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Registration of research studies

Not applicable.

Guarantor

Jason Laurens.

Provenance and peer review

Not commissioned, externally peer-reviewed.

CRediT authorship contribution statement

Jason Russell Laurens: Conceptualization, Investigation, Writing - original draft, Writing - review & editing. Adam John Frankel: Conceptualization, Supervision, Writing - review & editing. Bernard Mark Smithers: Supervision, Writing - review & editing.
  10 in total

1.  The SCARE 2018 statement: Updating consensus Surgical CAse REport (SCARE) guidelines.

Authors:  Riaz A Agha; Mimi R Borrelli; Reem Farwana; Kiron Koshy; Alexander J Fowler; Dennis P Orgill
Journal:  Int J Surg       Date:  2018-10-18       Impact factor: 6.071

2.  Case 2. Desmoplastic small cell tumor with divergent differentiation.

Authors:  W L Gerald; J Rosai
Journal:  Pediatr Pathol       Date:  1989

3.  Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants.

Authors:  W L Gerald; M Ladanyi; E de Alava; M Cuatrecasas; B H Kushner; M P LaQuaglia; J Rosai
Journal:  J Clin Oncol       Date:  1998-09       Impact factor: 44.544

Review 4.  Desmoplastic small round cell tumour: a description of two cases and review of the literature.

Authors:  Paolo Lippe; Rossana Berardi; Claudia Cappelletti; Cristian Massacesi; Rodolfo Mattioli; Luciano Latini; Riccardo Cellerino
Journal:  Oncology       Date:  2003       Impact factor: 2.935

5.  Clinical perspective on desmoplastic small round-cell tumor.

Authors:  Alberto Gil; Alberto Gomez Portilla; Erwin A Brun; Paul H Sugarbaker
Journal:  Oncology       Date:  2004       Impact factor: 2.935

6.  Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 Trial.

Authors:  Andrea A Hayes-Jordan; Brian A Coakley; Holly L Green; LianChun Xiao; Keith F Fournier; Cynthia E Herzog; Joseph A Ludwig; Mary F McAleer; Peter M Anderson; Winston W Huh
Journal:  Ann Surg Oncol       Date:  2018-01-30       Impact factor: 5.344

Review 7.  Desmoplastic small round cell tumour: a review of literature and treatment options.

Authors:  C E Stuart-Buttle; C J Smart; S Pritchard; D Martin; I M Welch
Journal:  Surg Oncol       Date:  2008-01-10       Impact factor: 3.279

8.  Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor.

Authors:  W L Gerald; J Rosai; M Ladanyi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

9.  Desmoplastic small round cell tumor: current management and recent findings.

Authors:  Armelle Dufresne; Philippe Cassier; Laure Couraud; Perrine Marec-Bérard; Pierre Meeus; Laurent Alberti; Jean-Yves Blay
Journal:  Sarcoma       Date:  2012-03-29

10.  Peritonectomy and hyperthermic intraperitoneal chemotherapy as treatment for desmoplastic small round cell tumour.

Authors:  Howard S Fan; Bernie I'Ons; Ryan McConnell; Varahini Kumar; Saleh Alzahrani; David L Morris
Journal:  Int J Surg Case Rep       Date:  2014-12-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.